India's pharmaceutical industry is on track to miss its ambitious 2030 export target of $130 billion, with sector leaders now projecting a revised figure of approximately $90 billion — a…
India’s drug regulator is building a fully digital, end-to-end regulatory platform — and the first phase is expected to go live within 18 months. The announcement, made by Drugs Controller…
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), is pushing forward with the most significant digital overhaul of its drug approval system in years. The Central Drugs Laboratory…
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has granted AstraZeneca permission to market its HER2-targeting cancer therapy Enhertu (trastuzumab deruxtecan) for a new, expanded breast cancer indication,…